Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/3/15 → 12/31/19 |
Funding
- PPD Development (Prot # GT-026)
- Galectin Therapeutics Inc. (Prot # GT-026)
Adverse Event for "A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients with N
- Rinella, Mary Eugenia (PD/PI)
Project: Research project